|
|
|
|
|
|
|
||
J. Gen. Physiol.,
Volume 111, Number 4, April 1, 1998 539-554
From the Department of Physiology, Botterell Hall, Queen's University, Kingston, Ontario, Canada K7L 3N6
4-Aminopyridine (4-AP) binds to potassium channels at a site or sites in the inner mouth of the pore
and is thought to prevent channel opening. The return of hKv1.5 off-gating charge upon repolarization is accelerated by 4-AP and it has been suggested that 4-AP blocks slow conformational rearrangements during late closed
states that are necessary for channel opening. On the other hand, quinidine, an open channel blocker, slows the
return or immobilizes off-gating charge only at opening potentials (>
25 mV). The aim of this study was to use quini-dine as a probe of open channels to test the kinetic state of 4-AP-blocked channels. In the presence of 0.2-1 mM
4-AP, quinidine slowed charge return and caused partial charge immobilization, corresponding to an increase in
the Kd of ~20-fold. Peak off-gating currents were reduced and decay was slowed ~2- to 2.5-fold at potentials negative to the threshold of channel activation and during depolarizations shorter than normally required for channel
activation. This demonstrated access of quinidine to 4-AP-blocked channels, a lack of competition between the
two drugs, and implied allosteric modulation of the quinidine binding site by 4-AP resident within the channel.
Single channel recordings also showed that quinidine could modulate the 4-AP-induced closure of the channels,
with the result that frequent channel reopenings were observed when both drugs were present. We propose that
4-AP-blocked channels exist in a partially open, nonconducting state that allows access to quinidine, even at more
negative potentials and during shorter depolarizations than those required for channel activation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Abi-Char, S. El-Haou, E. Balse, N. Neyroud, R. Vranckx, A. Coulombe, and S. N. Hatem The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1851 - H1861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Vargas, R. Garcia-Salcedo, S. Tenreiro, M. C. Teixeira, A. R. Fernandes, J. Ramos, and I. Sa-Correia Saccharomyces cerevisiae Multidrug Resistance Transporter Qdr2 Is Implicated in Potassium Uptake, Providing a Physiological Advantage to Quinidine-Stressed Cells Eukaryot. Cell, February 1, 2007; 6(2): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. H. Kwan, C. Eduljee, L. Lee, S. Zhang, D. Fedida, and S. J. Kehl The External K+ Concentration and Mutations in the Outer Pore Mouth Affect the Inhibition of Kv1.5 Current by Ni2+ Biophys. J., April 1, 2004; 86(4): 2238 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Hesketh and D. Fedida Sequential gating in the human heart K+ channel Kv1.5 incorporates Q1 and Q2 charge components Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1956 - H1966. [Abstract] [Full Text] [PDF]
|
|
|
|
